569 related articles for article (PubMed ID: 28974394)
21. Redefining MDR-TB: Comparison of Mycobacterium tuberculosis clinical isolates from Russia and Taiwan.
Jou R; Lee WT; Kulagina EV; Weng JY; Isakova AI; Lin WH; Antonova OV; Wu MH; Arslanbaeva LR; Tasi HY; Nosova EY; Zimenkov DV
Infect Genet Evol; 2019 Aug; 72():141-146. PubMed ID: 30593924
[TBL] [Abstract][Full Text] [Related]
22. Analytical and clinical performance characteristics of the Abbott RealTime MTB RIF/INH Resistance, an assay for the detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis in pulmonary specimens.
Kostera J; Leckie G; Tang N; Lampinen J; Szostak M; Abravaya K; Wang H
Tuberculosis (Edinb); 2016 Dec; 101():137-143. PubMed ID: 27865383
[TBL] [Abstract][Full Text] [Related]
23. Extensively and pre-extensively drug resistant tuberculosis in clinical isolates of multi-drug resistant tuberculosis using classical second line drugs (levofloxacin and amikacin).
Mirza IA; Khan FA; Khan KA; Satti L; Ghafoor T; Fayyaz M
J Coll Physicians Surg Pak; 2015 May; 25(5):337-41. PubMed ID: 26008658
[TBL] [Abstract][Full Text] [Related]
24. Molecular and phenotypic characterisation of Mycobacterium tuberculosis resistant to anti-tuberculosis drugs.
Imperiale BR; Zumárraga MJ; Di Giulio AB; Cataldi AA; Morcillo NS
Int J Tuberc Lung Dis; 2013 Aug; 17(8):1088-93. PubMed ID: 23827034
[TBL] [Abstract][Full Text] [Related]
25. Detection of Rifampicin- and Isoniazid-Resistant Mycobacterium tuberculosis Using the Quantamatrix Multiplexed Assay Platform System.
Wang HY; Uh Y; Kim S; Cho E; Lee JS; Lee H
Ann Lab Med; 2018 Nov; 38(6):569-577. PubMed ID: 30027701
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of a Rapid Molecular Drug-Susceptibility Test for Tuberculosis.
Xie YL; Chakravorty S; Armstrong DT; Hall SL; Via LE; Song T; Yuan X; Mo X; Zhu H; Xu P; Gao Q; Lee M; Lee J; Smith LE; Chen RY; Joh JS; Cho Y; Liu X; Ruan X; Liang L; Dharan N; Cho SN; Barry CE; Ellner JJ; Dorman SE; Alland D
N Engl J Med; 2017 Sep; 377(11):1043-1054. PubMed ID: 28902596
[TBL] [Abstract][Full Text] [Related]
27. Utilization of Truenat chips in defining XDR, pre-XDR and MDR in tuberculous meningitis.
Sharma K; Sharma M; Shree R; Singla N; Joshi H; Modi T; Goyal M; Sharma A; Sharma N; Modi M
Tuberculosis (Edinb); 2024 Jul; 147():102513. PubMed ID: 38547569
[TBL] [Abstract][Full Text] [Related]
28. Performance of REBA MTB-XDR to detect extensively drug-resistant tuberculosis in an intermediate-burden country.
Lee YS; Kang MR; Jung H; Choi SB; Jo KW; Shim TS
J Infect Chemother; 2015 May; 21(5):346-51. PubMed ID: 25634305
[TBL] [Abstract][Full Text] [Related]
29. Multicenter Evaluation of Anyplex Plus MTB/NTM MDR-TB Assay for Rapid Detection of Mycobacterium tuberculosis Complex and Multidrug-Resistant Isolates in Pulmonary and Extrapulmonary Specimens.
Sali M; De Maio F; Caccuri F; Campilongo F; Sanguinetti M; Fiorentini S; Delogu G; Giagulli C
J Clin Microbiol; 2016 Jan; 54(1):59-63. PubMed ID: 26491178
[TBL] [Abstract][Full Text] [Related]
30. Whole genome sequencing of clinical samples reveals extensively drug resistant tuberculosis (XDR TB) strains from the Beijing lineage in Nigeria, West Africa.
Olawoye IB; Uwanibe JN; Kunle-Ope CN; Davies-Bolorunduro OF; Abiodun TA; Audu RA; Salako BL; Happi CT
Sci Rep; 2021 Aug; 11(1):17387. PubMed ID: 34462504
[TBL] [Abstract][Full Text] [Related]
31. [Detection of tuberculosis genes associated with drug-resistance in paraffin-embedded tissue specimens using next generation sequencing technology].
Song J; Zhang ZG; Dong YJ; Du WL; Wang YX; Liu ZC; Li K; Zhang Q; Sun Q; Che NY
Zhonghua Jie He He Hu Xi Za Zhi; 2020 Mar; 43(3):234-241. PubMed ID: 32164095
[No Abstract] [Full Text] [Related]
32. Drug Resistance Characteristics of
Wu X; Yang J; Tan G; Liu H; Liu Y; Guo Y; Gao R; Wan B; Yu F
Front Cell Infect Microbiol; 2019; 9():345. PubMed ID: 31828045
[No Abstract] [Full Text] [Related]
33. Multi-center evaluation of GenoType MTBDRsl line probe assay for rapid detection of pre-XDR and XDR Mycobacterium tuberculosis in China.
Gao Y; Zhang Z; Deng J; Mansjö M; Ning Z; Li Y; Li X; Hu Y; Hoffner S; Xu B
J Infect; 2018 Oct; 77(4):328-334. PubMed ID: 29969597
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of the microscopic observation drug susceptibility assay for the rapid detection of MDR-TB and XDR-TB in China: a prospective multicentre study.
Huang Z; Qin C; Du J; Luo Q; Wang Y; Zhang W; Zhang X; Xiong G; Chen J; Xu X; Li W; Li J
J Antimicrob Chemother; 2015 Feb; 70(2):456-62. PubMed ID: 25266071
[TBL] [Abstract][Full Text] [Related]
35. Drug resistance patterns among extra-pulmonary tuberculosis cases in a tertiary care centre in North India.
Sharma SK; Chaubey J; Singh BK; Sharma R; Mittal A; Sharma A
Int J Tuberc Lung Dis; 2017 Oct; 21(10):1112-1117. PubMed ID: 28911354
[TBL] [Abstract][Full Text] [Related]
36. Rapid detection of extensively drug-resistant (XDR-TB) strains from multidrug-resistant tuberculosis (MDR-TB) cases isolated from smear-negative pulmonary samples in an Intermediate Reference Laboratory in India.
Vashistha H; Hanif M; Saini S; Khanna A; Sharma S; Sidiq Z; Ahmed V; Dubey M; Chopra KK; Shrivastava D
Indian J Tuberc; 2016 Jul; 63(3):144-148. PubMed ID: 27865234
[TBL] [Abstract][Full Text] [Related]
37. Detection of isoniazid, fluoroquinolone, ethionamide, amikacin, kanamycin, and capreomycin resistance by the Xpert MTB/XDR assay: a cross-sectional multicentre diagnostic accuracy study.
Penn-Nicholson A; Georghiou SB; Ciobanu N; Kazi M; Bhalla M; David A; Conradie F; Ruhwald M; Crudu V; Rodrigues C; Myneedu VP; Scott L; Denkinger CM; Schumacher SG;
Lancet Infect Dis; 2022 Feb; 22(2):242-249. PubMed ID: 34627496
[TBL] [Abstract][Full Text] [Related]
38. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
Park SK; Kim JH; Kang H; Cho JS; Smego RA
Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
[TBL] [Abstract][Full Text] [Related]
39. Role of real-time PCR for detection of tuberculosis and drug resistance directly from clinical samples.
Rao P; Chawla K; Shenoy VP; Mukhopadhyay C
Indian J Tuberc; 2016 Jul; 63(3):149-153. PubMed ID: 27865235
[TBL] [Abstract][Full Text] [Related]
40. Detection of second-line drug resistance in Mycobacterium tuberculosis using oligonucleotide microarrays.
Zimenkov DV; Antonova OV; Kuz'min AV; Isaeva YD; Krylova LY; Popov SA; Zasedatelev AS; Mikhailovich VM; Gryadunov DA
BMC Infect Dis; 2013 May; 13():240. PubMed ID: 23705640
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
